AmCad BioMed Corporation (TPEX:4188)
Taiwan · Delayed Price · Currency is TWD 14.20
+0.45 (3.27%)
Feb 11, 2026, 1:30 PM CST
AmCad BioMed Market Cap
AmCad BioMed has a market cap or net worth of 899.33 million as of February 13, 2026. Its market cap has decreased by -33.95% in one year.
Market Cap
899.33M
Enterprise Value
607.13M
Revenue
43.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.20
Market Cap Chart
Since December 26, 2013, AmCad BioMed's market cap has decreased from 905.63M to 899.33M, a decrease of -0.70%. That is a compound annual growth rate of -0.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 899.33M | -3.40% |
| Dec 31, 2025 | 930.99M | -34.23% |
| Dec 31, 2024 | 1.42B | -0.45% |
| Dec 29, 2023 | 1.42B | 67.51% |
| Dec 30, 2022 | 848.88M | -17.57% |
| Dec 30, 2021 | 1.03B | 0.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Biomaterial | 1.75B |
| Cowealth Medical Holding | 1.69B |
| Bioptik Technology Incorporation | 1.53B |
| Rossmax International | 1.42B |
| AViTA | 1.23B |
| Wiltrom | 1.14B |
| PlexBio | 861.33M |
| Radiant Innovation | 857.14M |